Continuous renal replacement techniques

Contributions to Nephrology

Volumn 144, Issue , 2004, Pages 264-277

  Clark, William R ^a,b,d   Ronco, Claudio ^c  

^a NxStage Medical Inc   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SAN BORTOLO HOSPITAL   (Italy)

^d WISHARD MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WATER;

ACUTE KIDNEY FAILURE; DIFFUSION; HEMODIAFILTRATION; HEMOFILTRATION; HUMAN; INTENSIVE CARE UNIT; METABOLISM; METHODOLOGY; RENAL REPLACEMENT THERAPY; REVIEW; TRANSPORT AT THE CELLULAR LEVEL;

BIOLOGICAL TRANSPORT; DIFFUSION; HEMODIAFILTRATION; HEMOFILTRATION; HUMANS; INTENSIVE CARE UNITS; KIDNEY FAILURE, ACUTE; RENAL DIALYSIS; RENAL REPLACEMENT THERAPY; WATER;

EID: 3342988421     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000078894     Document Type: Article

References (51)

1. Bellomo R, Ronco C: Acute renal failure in the ICU: Adequacy of dialysis and the case for continuous therapies. Nephrol Dial Transplant 1996;11:424-428.
2. Bellomo R, Ronco C: Continuous versus intermittent renal replacement therapy in the intensive care unit. Kidney Int 1998;53(suppl 66):S125-S128.
3. Ronco C, Ghezzi P, Bellomo R: New perspective in the treatment of acute renal failure. Blood Purif 1999;17:166-172.
4. Henderson LW: Biophysics of ultrafiltration and hemofiltration; in Jacobs C (ed): Replacement of Renal Function by Dialysis, ed 4. Dortdrecht, Kluwer Academic Publishers, 1996, pp 114-118.
5. Rockel A, Hertel J, Fiegel P, Abdelhamid S, Panitz N, Walb D: Permeability and secondary membrane formation of a high flux polysufone hemofilter. Kidney Int 1986;30:429-432.
6. Langsdorf LJ, Zydney AL: Effect of blood contact on the transport properties of hemodialysis membranes: A two-layer model. Blood Purif 1994;12:292-307.
7. Morti SM, Zydney AL: Protein-membrane interactions during hemodialysis: Effects on solute transport. ASAIO J 1998;44:319-326.
8. Ronco C: Continuous renal replacement therapies in the treatment of acute renal failure in intensive care patients. [.Theoretical aspects and techniques. Nephrol Dial, Transplant 1994;9(suppl 4):191-200.
9. Clark WR, Ronco C: Determinants of hemodialyzer performance and the effect on clinical outcome. Nephrol Dial Transplant 2001;16(suppl 3):56-60.
10. Clark WR, Ronco C: Renal replacement therapy in acute renal failure: Solute removal mechanism and dose quantification. Kidney Int 1998;53(suppl 66):S133-S137.
11. Silverstein ME, Ford C A, Lysaght MJ, Henderson LW: Treatment of severe fluid overload by ultrafiltration. N Engl J Med 1974;291:747-751.
12. Paganini EP, Nakamoto S: Continuous slow ultrafiltration in oliguric acute renal failure. Trans Am Soc Artif Intern Organs 1980;26:201-204.
13. Macias WL, Mueller BA, Scarim SK, Robinson M, Rudy D: Continuous venovenous hemofiltration: An alternative to continuous arteriovenous hemofiltration and hemodiafiltration in acute renal failure. Am J Kidney Dis 1991;18:451-458.
14. Henderson LW: Pre- vs. post-dilution hemofiltration. Clin Nephrol 1979;11:120-124.
15. Clark WR, Turk JE, Kraus MA, Gao D: Dose determinants in continuous renal replacement therapy. Artif Organs 2003;27:815-820.
16. Liao Z, Zhang W, Poh CK, Huang Z, Hardy PA, Kraus MA, Clark WR, Gao D: Kinetic comparison of different acute dialysis therapies. Artif Organs 2003;27:802-807.
17. Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccinni P, La Greca G: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 2000;356:26-30.
18. Grootendorst F, Van Bommel E, Van De Hoven B: Light-volume hemofiltration improves hemodynamics of endotoxin-induced shock in the pig. Int Care Med 1992;18:235-240.
19. Grootendorst F, Van Bommel E, Van Leenooed L, Van De Hoven B: Infusion of ultrafiltrate from endotoxemic pigs depresses myocardial performance in normal pigs. J Crit Care 1993;8:161-169.
20. Ahuja A, Rodby R, Huang Z, Gao D, Zhang W, Clark WR: Effect of pre-dilution replacement fluid administration on solute clearance in high-volume hemofiltration (abstract). J Am Soc Nephrol 2003;14:734 A.
21. Sigler MH, Teehan BP: Solute transport in continous hemodialysis: A new treatment for acute renal failure. Kidney Int 1987;32:562-571.
22. Relton S, Greenberg A, Palevsky P: Dialysate and blood flow dependence of diffusive solute clearance during CWHD. ASAIO J 1992;38:691-696.
23. Ronco C, Ghezzi PM, Hoenich N, Delfino PG: Membranes and filters for hemodialysis. Contr Nephrol. Basel, Karger, 2000.
24. Bonnardeaux A, Pichette V, Ouimet D, Geadah D, Habel F, Cardinal J: Solute clearances with high dialysate flow rates and glucose absorption from the dialysate in continuous arteriovenous hemodialysis. Am J Kidney Dis 1992;19:31-38.
25. Brunei S, Leblanc M, Geadah D, Parent D, Corteau S, Cardinal J: Diffusive and convective solute clearance during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates. Am J Kidney Dis 1999;34:486-4192.
26. Schlaeper C, Amerling R, Manns M, Levin NW: High clearance continuous renal replacement therapy with a modified dialysis machine. Kidney Int Suppl 1999;72:S20-S23.
27. Clark WR, Ronco C: CRRT efficiency and efficacy in relation to solute size. Kidney Int 1999;56(suppl 72):S3-S7.
28. Troyanov S, Cardinal J, Geadah D, Parent D, Courteau S, Caron S, Leblanc M: Solute clearances during continuous venvenous haemofiltration at various ultrafiltration flow rates using Multiflow100 and HF1000 filters. Nephrol Dial Transplant 2003;18:961-966.
29. Ronco C: Continuous renal replacement therapies for the treatment of acute renal failure in intensive care patients. Clin Nephrol 1993;4:187-198.
30. Ronco C, Ghezzi PM, Hoenich N, Delfino PG: Membranes and filters for hemodialysis. Contr Nephrol. Basel, Karger, 2000.
31. Clark WR, Gao D: Low-molecular weight proteins in end-stage renal disease: Potential toxicity and dialytic removal mechanisms. J Am Soc Nephrol 2002;13:S41-S47.
32. Mehta RL: Therapeutic alternatives to renal replacement for critically ill patients in acute renal failure. Semin Nephrol 1994;14:64-82.
33. Pedrini LA, de Christofaro Y Pagliari B, Sama F: Mixed predilution and post-dilution online hemodiafiltration compared with traditional infusion modes. Kidney Int 2000;58:2155-2165.
34. Ronco C, Bellomo R: Critical Care Nephrology. Dortrecht, Kluwer Academic Publishers, 1998.
35. Ronco C, Brendolan A, Bellomo R: On-Line monitoring in continuous renal replacement therapies. Kidney Int 1999;56(suppl 72):S8-S14.
36. Rahmati S, Ronco F, Spittle M, Morris AT, Schlaeper C, Rosales L, Kaufman A, Amerling R, Ronco C, Levin NW: Validation of the blood temperature monitor for extracorporeal thermal energy balance during in vitro continuous hemodialysis. Blood Purif 2001;19:245-250.
37. Ronco C, Brendolan A, Bellomo R: Current technology for continuous renal replacement therapies; in Ronco C, Bellomo R (eds): Critical Care Nephrology. Dortrecht, Kluwer Academic Publishers, 1998, pp 1269-1308.
38. Clark WR, Leypoldt JK, Henderson LW, Mueller BA, Scott MK, Vonesh EF: Quantifying the effect of changes in the hemodialysis prescription on effective solute removal with a mathematical model. J Am Soc Nephrol 1999;10:601-610.
39. Clark WR, Mueller BA, Kraus MA, Macias WL: Extracorporeal therapy requirements for patients with acute renal failure. J Am Soc Nephrol 1997;8:804-812.
40. Gotch F: The current place of urea kinetic modeling with respect to different dialysis schedules. Nephrol Dial Transplant 1998;13(suppl 6):10-14.
41. TettaC, Mariano F, Ronco C, Bellomo R: Removal and generation of inflammatory mediators during continuous renal replacement therapies; in Ronco C, Bellomo R (eds): Critical Care Nephrology. Dortrecht, Kluwer Academic Publishers, 1998, pp 1239-1248.
42. Bellomo R, Baldwin I, Cole L, Ronco C: Preliminary experience with high volume hemofiltration in human septic shock. Kidney Int 1998;53(suppl 66):S182-S185.
43. Marenzi G, Grazi S, Giraldi F, et al: Interrelation of humoral factors, hemodynamics, and fluid and salt metabolism in congestive heart failure: Effect of extracorporeal ultrafiltration. Am J Med 1993;94:49-56.
44. Agostoni P, Marenzi G, Pepi M, et al: Isolated ultrafiltration in moderate congestive heart failure. J Am Coll Cardiol 1993;21:424-4131.
45. Agostoni P, Marenzi G, Lauri G, et al: Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: Failure of furosemide to provide the same result. Am J Med 1994;96:191-199.
46. Blake P, Paganini EP: Refractory congestive heart failure: Overview and application of extracorporeal ultrafiltration. Adv Ren Replace Ther 1996;3:166-173.
47. Canaud B, Leblanc M, Leray-Moragues H, Delmas S, Klouche K, Beraud JJ: Slow continuous and daily ultrafiltration for refractory congestive heart failure. Nephrol Dial Transplant 1998;13(suppl4):51-55.
48. Ronco C, Ricci Z, Bellomo R, Bedogni F: Extracorporeal ultrafiltration for the treatment of overhydration and congestive heart failure. Cardiology 2001;96:155-168.
49. Marenzi G, Lauri G, Grazi M, Assanelli E, Campodonico J, Agostoni P: Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol 2001;38:963-968.
50. Ronco C, Bellomo R, Ricci Z: Hemodynamic response to fluid withdrawal in overhydrated patients treated with intermittent ultrafiltration and slow continuous ultrafiltration: Role of blood volume monitoring. Cardiology 2001;96:196-201.
51. Ronco C, Bellomo R: Continuous versus intermittent renal replacement therapy in the treatment of acute renal failure. Nephrol Dial Transplant 1998;13:79-85.